Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0920
-0.0030 (-3.16%)
Aug 26, 2026, 4:10 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 29.19 million as of August 26, 2026. Its market cap has decreased by -4.88% in one year.
Market Cap
29.19M
Enterprise Value
33.34M
Revenue
3.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 29.19M, an increase of 109.88%. That is a compound annual growth rate of 7.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 28.27M | 4.00% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 48.05M |
| Radiopharm Theranostics | 45.54M |
| Neurizon Therapeutics | 44.96M |
| Imugene | 38.69M |
| Proteomics International Laboratories | 27.26M |
| NeuroScientific Biopharmaceuticals | 25.33M |
| Argenica Therapeutics | 25.05M |
| EZZ Life Science Holdings | 24.48M |